Persistence and adherence to HDM SLIT in Japanese children with allergic rhinitis: A multicenter, prospective, observational study.
Not Applicable
- Conditions
- Allergic rhinitis
- Registration Number
- JPRN-UMIN000040007
- Lead Sponsor
- Tokyo Metropolitan Children's Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
1: Patients who have received dust mite immunotherapy. 2: Patients receiving biologic therapy at the start of Miticure administration. 3: Patients who have been receiving systemic steroids for more than 28 days at the start of Miticure administration. 4: Patients considered ineligible by the principal investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Persistence rate of HDM SLIT.
- Secondary Outcome Measures
Name Time Method 1: Factors associated with HDM SLIT persistence. 2: Factors associated with clinical effects. 3: Sensitization status at the start of HDM SLIT. 4: Factors associated with changes in sensitization status after HDM SLIT.